AIE Bioscience (Guangdong) Co., Ltd. has been recognized with a 2026 Global Recognition Award in Innovation for its work in skin regeneration science, which centers on AIE smart vesicle technology and dormant lyophilization. Its Qiaoluoshi brand applies these technologies to products for aging, sensitive, and damaged skin.

Innovation Built on Cellular Regeneration

AIE Bioscience earned the award in Innovation because it reconsidered how skincare actives reach the skin, and its approach differs from products that act only on the surface. Its smart vesicles hold repair factors and anti-inflammatory signals in carriers measuring 30 to 150 nanometers, which pass through the epidermis to the basal layer and release their contents by membrane fusion. Transdermal absorption reports from the Chinese Academy of Inspection and Quarantine support this penetration, and they address the shallow absorption that limits many conventional formulas.

Dormant lyophilization is the second part of the work, since freeze-drying seals in the active ingredients and preserves their biological activity without chemical preservatives. Once reconstituted, products are stored at 2 to 8 degrees Celsius so that potency is protected until use, and the formula pairs multiple high-activity factors with niacinamide, tranexamic acid, and trehalose for repair and brightening. The two technologies work together because the vesicles carry the factors to the depth where they act, while freeze-drying keeps those factors active until application.

Scientific Validation and Production Standards

The Qiaoluoshi brand follows the principle of respecting the skin’s physiological laws, and its products send repair signals to every layer of the skin instead of treating only the surface. This prompts fibroblasts to produce collagen and elastin on their own, which supports full-thickness structural repair and maintains the immune barrier. Clinical tests and experimental validations have shown safety and measurable effects in accelerating cellular renewal, inhibiting melanin, reducing inflammation, desensitizing the skin, and repairing the barrier.

The core technology holds three international INCI certifications, and its exosome application technology has been included in authoritative medical monographs that more than a hundred medical experts have recognized. Production runs under a cGMP pharmaceutical system and meets FDA CFSAN GMP and ISO22716:2007 standards, while bio-sourced ingredients avoid the variables of agricultural supply chains. The formulas follow clean label principles, so they contain no artificial colors, artificial preservatives, added sugars, fragrances, fluorescent agents, mineral oils, or hormones.

Final Words

Nominations for a 2026 Global Recognition Award undergo initial screening by a panel of experts selected for their expertise and impartiality, and applicants must show excellence in areas such as leadership, service, research, innovation, teaching, mentoring, or artistic accomplishment. Each applicant is graded from 1, which is minimal, to 5, which is exceptional or world-class, and shortlisted applicants are then evaluated with the Rasch model. That model builds a linear measurement scale for each category, which allows precise comparison between applicants who excel in different areas.

AIE Bioscience met this standard through the originality and rigor of its technology, and its sustainability practices strengthen that case further. Its packaging favors recyclable and biodegradable materials, and tight control of manufacturing parameters lowers energy use and pollutant emissions. A spokesperson for Global Recognition Awards, Alex Sterling, said, “AIE Bioscience (Guangdong) Co., Ltd. earned a 2026 Global Recognition Award in Innovation because its smart vesicle and lyophilization technologies deliver validated, cellular-level skin repair while holding to strict safety and environmental standards.”